Julia Arnsten
Overview
Explore the profile of Julia Arnsten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
410
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopes S, Dotherow J, Pericot-Valverde I, Lum P, Taylor L, Mehta S, et al.
Drug Alcohol Depend
. 2025 Mar;
270:112617.
PMID: 40031361
Introduction: Integrating patient navigation (PN) interventions in hepatitis C virus (HCV) elimination efforts enhances HCV treatment cascade outcomes from screening to cure. Nonetheless, little is known about how the patient-navigator...
2.
Chaudary J, Rawat S, Dange A, Golub S, Kim R, Chakrapani V, et al.
JMIR Res Protoc
. 2024 Nov;
13:e59873.
PMID: 39499921
Background: Current programs to engage marginalized populations such as gay and bisexual individuals and other men who have sex with men (MSM) in HIV prevention interventions do not often reach...
3.
Tsui J, Ludwig-Barron N, James J, Heo M, Sivaraj L, Arnsten J, et al.
J Addict Med
. 2024 Oct;
PMID: 39475112
Background: Questions remain on the relationship between pain and hepatitis C virus cure among persons who inject drugs (PWID). This study aimed to explore whether achieving hepatitis C virus cure...
4.
Litwin A, Tsui J, Heo M, Mehta S, Taylor L, Lum P, et al.
JAMA Netw Open
. 2024 Aug;
7(8):e2430024.
PMID: 39186268
Importance: Hepatitis C virus (HCV) reinfection after curative treatment remains a concern for people who inject drugs. Objective: To assess the incidence of HCV reinfection and associated risk factors. Design,...
5.
Jakubowski A, Singh-Tan S, Torres-Lockhart K, Lu T, Arnsten J, Southern W, et al.
J Gen Intern Med
. 2024 Aug;
39(15):2961-2969.
PMID: 39136887
Background: Despite rising hospitalizations for opioid use disorder (OUD), rates of inpatient medications for OUD (MOUD) initiation are low. Addiction consult services (ACSs) facilitate inpatient MOUD initiation and linkage to...
6.
Lopes S, Pericot-Valverde I, Dotherow J, Lum P, Taylor L, Mehta S, et al.
Drug Alcohol Depend
. 2024 Jul;
262:111384.
PMID: 38991632
Background: Self-efficacy, a patient-level factor, has been shown to facilitate patient engagement in treatment and optimize treatment-related outcomes in various health contexts. Research on interventions supporting hepatitis C virus (HCV)...
7.
Lopes S, Pericot-Valverde I, Lum P, Taylor L, Mehta S, Tsui J, et al.
BMC Infect Dis
. 2024 Feb;
24(1):251.
PMID: 38395747
Background: Self-reported adherence to direct-acting antivirals (DAAs) to treat hepatitis C virus (HCV) among persons who inject drugs (PWID) is often an overreport of objectively measured adherence. The association of...
8.
Lopes S, Pericot-Valverde I, Arnsten J, Lum P, Taylor L, Mehta S, et al.
Int J Drug Policy
. 2023 Dec;
123:104288.
PMID: 38103458
Background: Objective adherence measures, such as electronic blister pack (BP), for direct-acting antivirals (DAAs) for hepatitis C virus (HCV) treatment have high accuracy, but their use is limited in real...
9.
Pericot-Valverde I, Byrne K, Ortiz E, Davis S, Hammond E, Nahvi S, et al.
Int J Environ Res Public Health
. 2023 Aug;
20(16).
PMID: 37623193
People on buprenorphine maintenance treatment (BMT) commonly present cognitive deficits that have been associated with illicit drug use and dropout from buprenorphine treatment. This study has compared cognitive responses to...
10.
Andrade E, Stoukides G, Santoro A, Karasz A, Arnsten J, Patel V
J Gen Intern Med
. 2023 Jul;
38(12):2768-2774.
PMID: 37429976
Background: Young Black and Latino men who have sex with men (YBLMSM) have the highest rates of new HIV infections in the USA and use PrEP at lower rates than...